In this study, a new cationic P(AAm-AETAC) hydrogels were prepared by radical addition reaction in aqueous solution with acrylamide and [2-(acryloyloxy)ethyl] trimethylammonium chloride) comonomers the presence of ethylene glycolmethacrylate. Hydrogels characterized spectroscopic, surface, thermal analysis. The hydrogel does not undergo any structural degradation effect heat up to 250 oC.The ad...

BACKGROUND Candida-associated denture stomatitis is the most common manifestation of oral candidal infection, caused mainly by Candida albicans. Several authors have attempted to add antifungal agents or antiseptics to denture temporary soft lining materials or to denture acrylic resins, without relevant results. Therefore, the investigation of a quaternary ammonium functionalized compound [2-(...

The aim of this study was to develop an experimental adhesive with addition of [2-(methacryloyloxy)ethyl]trimethylammonium chloride (METAC) and to evaluate its mechanical and biological properties and its in vitro antibacterial activity. An experimental adhesive resin was formulated with Bis-GMA, TEGDMA, and HEMA. The antibacterial monomer was added at concentrations of 1%, 2.5%, and 5% (METAC ...

Electrolysis is seen as a promising route for the production of hydrogen from water, part move to wider “hydrogen economy”. The electro-oxidation renewable feedstocks offers an alternative anode couple (high-overpotential) electrochemical oxygen evolution reaction developing low-voltage electrolysers. Meanwhile, exploration new membrane materials also important in order try and reduce capital c...

The ability of azobenzene trimethylammonium bromide (azoTAB) to sensitize cardiac tissue excitability to light was recently reported. The dark, thermally relaxed trans- isomer of azoTAB suppressed spontaneous activity and excitation propagation speed, whereas the cis- isomer had no detectable effect on the electrical properties of cardiomyocyte monolayers. As the membrane potential of cardiac c...

The ruthenium anticancer compound NAMI-A, imidazolium [trans-RuCl4(1H-imidazole)(DMSO-S)], is currently undergoing advanced clinical evaluation. As with other Ru(iii) chemotherapeutic candidates, interactions with human serum albumin (HSA) have been identified as a key component of the speciation of NAMI-A following intravenous administration. To characterize coordination to HSA, we have perfor...